Scientist, Department of Molecular Oncology, BC Cancer Agency; and Assistant Professor, Department of Pathology, UBC

Thank you for reading my posts thus far. I thought I would close with some thoughts on looking forward.

It is a particularly exciting time for cancer research and there are many reasons for patients to be optimistic that real progress is being made in our understanding of cancer. A major goal of the BC Cancer Agency is to translate research findings into clinical application.

The future directions for my lab are to investigate how clonal diversity in tumours impacts patient outcomes. We will ask questions like: Can the degree of clonal diversity within a patient's tumour predict how a patient responds to therapy? Are there certain mutations that allow tumours to become resistant to chemotherapy?

Addressing these questions will require ongoing support from the BC Cancer Foundation, and other organizations. Events like the BC Cancer Foundation’s epic new MOVEment, Bust a Move for Breast Health, and the Ride to Conquer Cancer, are essential fundraising tools that help scientists like me to answer critical questions about how tumours start, grow, spread and become resistant to therapy at the most fundamental level of the genome. There has never been a better time to support and promote research at the BC Cancer Agency.

We have shown that the synergy and collaborative environment here at the BC Cancer Agency can lead to landmark discoveries. We are ready to tackle the next set of questions and hope we can rely on your support.

Thank you for reading,

Sohrab